NCT03113929View on ClinicalTrials.gov

Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)

Active, not recruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Alcoholic Liver Disease
Interventions
RADIATION

MRI

Research MRI

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT03113929 - Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD) | Biotech Hunter | Biotech Hunter